ACTSI Investigator Dr. Mark Goodman in the News

Mark Goodman, PhD, ACTSI investigator and professor of radiology, psychiatry and hematology and oncology, Emory University School of Medicine

Lab Land | FDA approves Emory-developed cancer imaging probe
June 6, 2016

Emory News Center | FDA Approves Emory-Developed Prostate Cancer Imaging Probe
June 1, 2016

Yahoo News | U.S. FDA approves Blue Earth Diagnostics’ Axumin(TM) (Fluciclovine F 18) injection after priority review for PET imaging of recurrent prostate cancer
May 31, 2016

Goodman won the Start-up of 2015 Award from Emory’s Office of Technology Transfer for Microbial Medical

Lab Land | Promising probe for detecting recurrent prostate cancer
June 18, 2015

Emory News Center | Mark Goodman, PhD, earns nuclear medicine imaging award
June 1, 2012

Goodman’s project, Development and Preclinical Testing of a “L” Large Neutral Amino Acid Imaging Biomarker for Systemic Tumors with High LAT Expression was funded by the Winship Cancer Institute CCSG Fund (McCarty Fund)